$5.02
0.030.60%
At close: -
$5.20
0.183.59%
After Hours: Feb 14, 8:16 AM EDT
Comments
Loading...
Opthea (NASDAQ:OPT) Stock Quotes, Forecast and News Summary
Opthea Stock (NASDAQ: OPT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Opthea (OPT) stock?
You can purchase shares of Opthea (NASDAQ:OPT) through any online brokerage.
Who are Opthea (OPT) competitors?
Other companies in Opthea’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Valneva (NASDAQ:VALN) and Cogent Biosciences (NASDAQ:COGT).
What is the forecast, or price target, for Opthea (OPT) stock?
Opthea has a consensus price target of $24.00.
What is the current price for Opthea (OPT)?
The stock price for Opthea (NASDAQ: OPT) is $5.2 last updated February 14, 2025 at 8:16 AM EST.
Does Opthea (OPT) pay a dividend?
There are no upcoming dividends for Opthea.
When is Opthea (NASDAQ:OPT) reporting earnings?
Opthea’s H1 earnings are confirmed for Friday, March 7, 2025.
Is Opthea (OPT) going to split?
There is no upcoming split for Opthea.
What sector and industry does Opthea (OPT) operate in?
Opthea is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.